Paba/No As an Anticancer Lead: Analogue Synthesis, Structure Revision, Solution Chemistry, Reactivity Toward Glutathione, and in Vitro Activity.
From: Basic Research Program, SAIC Frederick, Chemistry Section, Laboratory of Comparative Carcinogenesis, and Biomolecular Structure Section, Macromolecular Crystallography Laboratory, National Cancer Institute at Frederick, Frederick, MD 21702, USA.
Journal of medicinal chemistry
- Publish Date: Feb 2006
- ISSN: 0022-2623
- Volume: 49
- Issue: 3
- Pages: 1157-64
- Medium: Print
- Language: English
- Citation (JAMA): Saavedra Joseph E, Srinivasan Aloka, Buzard Gregory S, et al. Paba/No As an Anticancer Lead: Analogue Synthesis, Structure Revision, Solution Chemistry, Reactivity Toward Glutathione, and in Vitro Activity.. J. Med. Chem. Feb 2006;49:1157-64
Abstract
PABA/NO is a diazeniumdiolate of structure Me(2)NN(O)=NOAr (where Ar is a 5-substituted-2,4-dinitrophenyl ring whose 5-substituent is N-methyl-p-aminobenzoic acid). It has shown activity against human ovarian cancer xenografts in mice rivaling that of cisplatin, but it is poorly soluble and relatively unstable in water. Here we report structure-based optimization efforts resulting in three analogues with improved solubility and stability in aqueous solution. We sought to explain PABA/NO’s physicochemical uniqueness among these four compounds, whose aminobenzoic acid precursors differ structurally only in the presence or absence of the N-methyl group and/or the position of the carboxyl moiety (meta or para). Studies revealed that PABA/NO’s N-methyl-p-aminobenzoic acid substituent is bound to the dinitrobenzene ring via its carboxyl oxygen while the other three are linked through the aniline nitrogen. This constitutes a revision of the previously published PABA/NO structure. All four analogues reacted with GSH to produce bioactive nitric oxide (NO), but PABA/NO was the most reactive. Consistent with PABA/NO’s potent suppression of A2780 human ovarian cancer xenograft growth in mice, it was the most potent of the four in the OVCAR-3 cell line.
Mesh Headings (Keywords): 4-Aminobenzoic Acid, Animals, Antineoplastic Agents, Azo Compounds, Cell Line, Tumor, Crystallography, X-Ray, Drug Screening Assays, Antitumor, Drug Stability, Glutathione, Humans, Hydrolysis, Mice, Mice, Inbred NOD, Mice, SCID, Nitric Oxide, Solubility, Structure-Activity Relationship, Transplantation, Heterologous
Check for Full Text / PubMed Unique Identifier (PMID): 16451080
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.